fig2
![Nanofibrillar collagen scaffolds for lymphedema treatment: current applications and future directions](https://image.oaes.cc/06982308-3878-41bc-b848-8b89b8161dde/5269.fig.2.jpg)
Figure 2. Utility of nanofibrillar biosynthetic scaffolds for lymphedema. VEGF: Vascular endothelial growth factor; VLNT: vascularized lymph node transfer; LVA: lymphaticovenous anastomosis.
Figure 2. Utility of nanofibrillar biosynthetic scaffolds for lymphedema. VEGF: Vascular endothelial growth factor; VLNT: vascularized lymph node transfer; LVA: lymphaticovenous anastomosis.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/